These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5608602)

  • 1. [Drugs, cosmetics and beverages: meaning and gaps in various rules governing their use].
    Silvestrini B
    Boll Chim Farm; 1967 Jan; 106(1):1-5. PubMed ID: 5608602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 3. The World Health Organization & pharmacy.
    Blanc P
    Am J Hosp Pharm; 1967 Sep; 24(9):484-93. PubMed ID: 6049807
    [No Abstract]   [Full Text] [Related]  

  • 4. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of tolerances, standards, and methodology in the enforcement of the Food, Drug, and Cosmetic Act.
    Eiduson HP
    J Chem Inf Comput Sci; 1977 May; 17(2):102-5. PubMed ID: 853069
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of drugs in man and animals.
    Uvarov O
    Proc R Soc Med; 1968 Jun; 61(6):569-74. PubMed ID: 4873871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Doctor and drugs].
    Emmrich R
    Z Arztl Fortbild (Jena); 1970 Nov; 64(21):1092-6. PubMed ID: 5505098
    [No Abstract]   [Full Text] [Related]  

  • 8. [The microflora in cosmetics and non-sterile pharmaceuticals, and the microbiological standards for these products. Microbiological standards for cosmetics and non-sterile pharmaceuticals. A survey (author's transl)].
    Christensen SG
    Nord Vet Med; 1979 Apr; 31(4):165-70. PubMed ID: 379804
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer-causing substances in food, drugs, and cosmetics.
    N Engl J Med; 1989 Apr; 320(14):934-6. PubMed ID: 2927465
    [No Abstract]   [Full Text] [Related]  

  • 10. [The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry].
    Lorusso S; Camoni I; Chiacchierini E
    Nuovi Ann Ig Microbiol; 1985; 36(3):169-80. PubMed ID: 3842759
    [No Abstract]   [Full Text] [Related]  

  • 11. [Supervision of cosmetic products].
    Urbanek-Karłowska B; Smietanka B; Pawłowska K; Biernat U; Burzyńska I
    Rocz Panstw Zakl Hig; 2001; 52(3):257-65. PubMed ID: 11771119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Drugs and Cosmetics Rules in general practice.
    Sarker BB
    Indian Med J; 1967 Jan; 61(1):22-3. PubMed ID: 6037500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Substances requiring prescriptions in cosmetics].
    Scherm A
    Asthet Med (Berl); 1969 Oct; 18(10):197-9. PubMed ID: 5312293
    [No Abstract]   [Full Text] [Related]  

  • 14. Formulation for optimal safety and effectiveness.
    Schlichting DA
    Am J Pharm Sci Support Public Health; 1970; 142(1):16-22. PubMed ID: 5535904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines on the use of medicinal plants].
    Battaglino G; Quercia V
    Boll Chim Farm; 1978 May; 117(5):251-7. PubMed ID: 743374
    [No Abstract]   [Full Text] [Related]  

  • 16. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
    Tetzlaff RF
    J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
    [No Abstract]   [Full Text] [Related]  

  • 17. [Technical-administrative aspects of the registration of pharmaceutical specialities].
    Marconi M; Battaglino G
    Boll Chim Farm; 1979 Mar; 118(3):118-34. PubMed ID: 475904
    [No Abstract]   [Full Text] [Related]  

  • 18. Preclearance of drug products--pharmacy's perspective.
    Feldmann EG
    Am Pharm; 1981 Jun; NS21(6):26-32. PubMed ID: 7246421
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical testing of drugs].
    Begemann H
    Med Klin; 1973 May; 68(18):569-71. PubMed ID: 4576603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.